Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thrombolysis in acute ischemic stroke

A Luisi1, A L Hume

  • 1Department of Pharmacy, University of Rhode Island, Kingston 02881, USA.

The Journal of the American Board of Family Practice
|June 6, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nonhormonal management of postmenopausal women: effects of a red clover based isoflavones supplementation on climacteric syndrome and cardiovascular risk serum profile.

Clinical and experimental obstetrics & gynecology·2013
Same author

Low-dose estrogen and drospirenone combination: effects on metabolism and endothelial function in postmenopausal women with metabolic syndrome.

Clinical and experimental obstetrics & gynecology·2013
Same author

Arterial hypertension and female sexual dysfunction in postmenopausal women.

Clinical and experimental obstetrics & gynecology·2013
Same author

Drug therapy and prevalence of erectile dysfunction in the Massachusetts Male Aging Study cohort.

Pharmacotherapy·2001
Same author

Pharmacologic treatment of diabetes in long-term care.

Journal of clinical epidemiology·2001
Same author

Cell proliferation and outcome following doxorubicin plus CMF regimens in node-positive breast cancer.

International journal of cancer·2000
Same journal

A molar pregnancy detected by following beta-human chorionic gonadotropin levels after a first trimester loss.

The Journal of the American Board of Family Practice·2005
Same journal

Successful treatment of chronic erythema nodosum with vitamin B12.

The Journal of the American Board of Family Practice·2005
Same journal

Patient satisfaction with migraine management by family physicians.

The Journal of the American Board of Family Practice·2005
Same journal

Reliability of the whiff test in clinical practice.

The Journal of the American Board of Family Practice·2005
Same journal

Effects of a reduced-visit prenatal care clinical practice guideline.

The Journal of the American Board of Family Practice·2005
Same journal

From specialty-based to practice-based: a new blueprint for the American Board of Family Medicine cognitive examination.

The Journal of the American Board of Family Practice·2005
See all related articles

Early treatment with recombinant tissue plasminogen activator (rt-PA) can improve outcomes for acute ischemic stroke patients. Strict adherence to eligibility criteria and a 3-hour window are crucial for safe and effective rt-PA administration.

Area of Science:

  • Neurology
  • Emergency Medicine
  • Pharmacology

Background:

  • Acute ischemic stroke requires timely intervention to mitigate brain damage.
  • Recombinant tissue plasminogen activator (rt-PA) is a key thrombolytic therapy.
  • Optimizing rt-PA use in clinical practice is essential for patient benefit.

Purpose of the Study:

  • To outline the critical criteria for the safe and effective administration of rt-PA.
  • To emphasize the importance of early presentation and symptom onset definition.
  • To detail the recommended dosage and infusion protocol for rt-PA.

Main Methods:

  • Review of established guidelines for rt-PA administration.
  • Emphasis on patient selection based on symptom onset and contraindications.

Related Experiment Videos

  • Description of the standard rt-PA dosage and intravenous infusion procedure.

    • Main Results:

    • Successful rt-PA administration requires early patient presentation and symptom onset.
    • Exclusion of hemorrhage via CT scan is a mandatory prerequisite.
    • Adherence to the 0.9 mg/kg dosage (max 90 mg) and 3-hour window is critical.

    Conclusions:

    • rt-PA offers significant potential for improving functional outcomes in acute ischemic stroke.
    • Strict adherence to patient selection criteria and treatment window is paramount for safety and efficacy.
    • While not all patients meet trial criteria, rt-PA represents a major therapeutic advance.